Heron Therapeutics, Inc. (NASDAQ:HRTX – Get Free Report) saw a significant increase in short interest in the month of May. As of May 15th, there was short interest totalling 30,270,000 shares, an increase of 10.9% from the April 30th total of 27,290,000 shares. Based on an average daily volume of 2,410,000 shares, the short-interest ratio […]
Heron Therapeutics, Inc. (NASDAQ:HRTX – Get Free Report) was the target of a large growth in short interest during the month of May. As of May 15th, there was short interest totalling 30,270,000 shares, a growth of 10.9% from the April 30th total of 27,290,000 shares. Based on an average trading volume of 2,410,000 shares, […]
Heron Therapeutics, Inc. (NASDAQ:HRTX – Get Free Report) was the recipient of a significant increase in short interest in the month of May. As of May 15th, there was short interest totalling 30,270,000 shares, an increase of 10.9% from the April 30th total of 27,290,000 shares. Based on an average daily trading volume, of 2,410,000 […]
Heron Therapeutics Inc. announced increased net product sales in its first quarter of 2024 financial results, according to a company press release.Heron Therapeutics reported $34.7 million in net product sales for the quarter, an increase from its reported $29.6 million in the first quarter of 2023. The company reported $5.5 million in net product sales for its acute care franchise and $29.2